Barriers to Follow-up for Women with a History of Gestational Diabetes by Stuebe, Alison et al.
Barriers to Follow-up for Women with a History of Gestational
Diabetes
Alison Stuebe, MD, MSc1, Jeffrey Ecker, MD2, David W. Bates, MD, MSc3, Chloe Zera, MD4,
Rhonda Bentley-Lewis, MD, MBA, MMSc5, and Ellen Seely, MD5
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of
North Carolina School of Medicine, 3010 Old Clinic Building, CB 7516, Chapel Hill, NC 27599
2Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Massachusetts
General Hospital, 55 Fruit Street, Boston, MA 02114
3Division of General Internal Medicine, Brigham and Women’s Hospital, Harvard Medical School,
and Harvard School of Public Health, 75 Francis Street, Boston, MA 02115
4Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive
Biology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115
5Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, 221
Longwood Avenue, Boston, MA 02115
Abstract
Objective—Women with gestational diabetes (GDM) are at increased risk for type 2 diabetes
(T2DM), but many do not receive recommended follow-up. We sought to identify barriers to
follow-up screening.
Study design—We surveyed primary care (PCPs) and obstetric and gynecology care providers
(OBCPs) in a large health system. We also assessed documentation of GDM history in the health
care system’s electronic medical record.
Results—478 clinicians were surveyed, among whom 207 responded. Most participants (81.1%)
gave an accurate estimate of risk of progression to T2DM. PCPs were less likely than OBCPs to
ask patients about history of GDM (OR 0.43, 95% CI 0.20–0.90), but they were far more likely to
indicate that they order glucose screening for women with a known history (OR 4.31, 95% CI
2.01–9.26). Providers identified poor communication between OBCPs and PCPs as a major barrier
to screening. Fewer than half (45.8%) of 450 women with GDM by GTT criteria had that history
documented on their electronic problem list.
Conclusions—Clinicians are aware that women with GDM are at high risk of developing type 2
diabetes, but they do not routinely assess and screen patients, and communication between OBCPs
and PCPs can be improved.
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Gestational diabetes affects from 2.2 to 8.8 percent of pregnant women, depending on the
population studied1. Gestational glucose intolerance identifies a group of women at high risk
of type 2 diabetes, and the American Diabetes Association2 and the American College of
Obstetricians and Gynecologists (ACOG)3 recommend glucose screening in the early
postpartum period. ACOG recently revised their recommendations to underscore the
importance of follow-up testing3. Following the early postpartum period, women with
normal glucose tolerance should be re-screened every three years, and those with impaired
glucose tolerance should be screened annually, with a fasting blood glucose or 2-hour oral
glucose tolerance test.
Population data suggest that appropriate screening is a major public health priority. In a
meta-analysis, Cheung et al4 estimated that one third of women with type 2 diabetes have
previously been diagnosed with GDM. Data from prevention studies suggest that early
detection and intervention for glucose intolerance can reduce progression to type 2 diabetes
by more than 50 percent5–8. Collectively, these data suggest that lifestyle interventions for
women with a history of gestational diabetes could delay or prevent one sixth of type 2
diabetes cases in the female population.
Despite the public health importance of follow-up screening, recent studies have reported
that less than 40 percent of women receive appropriate screening at the post-partum visit9,10,
and few studies have evaluated subsequent screening in primary care. This lack of
appropriate screening and follow-up may reflect both lack of communication between
obstetric and primary care providers as to pregnancy diagnoses and lack of knowledge of
appropriate screening guidelines. We sought to measure the effect of these barriers through a
survey of OB care providers (OBCPs) and primary care providers (PCPs) within a large
health care system in Boston, MA. In addition, we assessed how frequently a history of
GDM was routinely documented in the health care system’s electronic medical record.
Materials and Methods
We surveyed obstetrician-gynecologists, certified nurse-midwives, primary care physicians
and nurse-practitioners who provide care through outpatient clinics affiliated with
Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA. All
participating providers are part of the Partners Healthcare System, and they utilize the
Longitudinal Medical Record11, a fully-functional electronic medical record (EMR). Both
BWH and MGH have utilized electronic records for prenatal care since the mid-1990s,
although during the study period, both the MGH and BWH electronic prenatal records
operated independently of the primary care EMR.
Survey development
The authors developed survey questions based on previous surveys conducted at our
institution11 and evidence from the literature on barriers to guideline implementation12.
Topics covered included general knowledge regarding screening for diabetes, structural
features of the office practice, such as patient intake forms and patient educational materials,
perception of communication between OB and primary care providers, and routines
regarding assessment of reproductive and metabolic risk history. In addition, we assessed
providers’ opinions regarding potential barriers to follow-up of women with GDM, and
attitudes regarding patient response to preventive health counseling and use of electronic
medical records. The survey was pilot tested among a small group of physicians who were
not in the survey target population.
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We obtained lists of providers from the departments of obstetrics and gynecology and
internal medicine at the two institutions. The survey was administered via email using
Survey Monkey. Participants who responded were provided with a $5 coffee card as an
incentive. Three reminder emails were sent over a one-month period to encourage
participation.
Data analysis
We reported descriptive characteristics of our population using median and interquartile
range to describe age and year that participants completed training. We compared
categorical responses among OBCPs vs. PCPs using chi square tests. A p value < 0.05 was
considered statistically significant. We used logistic regression to test whether differences in
age or level of training modified associations between type of provider and likelihood of
screening for GDM. All analyses were performed using SAS 9.2 (Cary, NC).
Assessment of Electronic Medical Record Documentation of GDM
Glucose tolerance test results for women who received obstetric care at Brigham and
Women’s Hospital are available for research and quality tracking through the Partners
Clinical Data Warehouse. We queried this data set to identify women with a history of
gestational diabetes from 1995 to 2008. Using Carpenter-Coustan Criteria for the 100g 3-
hour Glucose Tolerance Test13, we identified women with GDM who delivered at BWH and
had laboratory values recorded in the clinical database. We then examined the electronic
medical record problem list. The LMR uses a concept code of “Diabetes of Pregnancy” for
women with a history of GDM. Because some clinicians use free text to enter diagnoses in
the problem list, we used a free text search algorithm (If [text matches 'diab' or 'dm'] AND
[text matches 'preg' or 'gest'] OR [text matches 'gdm'] then text for GDM=true) to identify
women whose providers had indicated a history of GDM. Among women with GDM by
Carpenter-Coustan Criteria who had at least one entry on their problem list, we calculated
the percent for whom a concept code for “Diabetes of Pregnancy” or a free text entry
indicating GDM was recorded.
The Institutional Review Board of Partners Healthcare approved the study and informed
consent was provided through participants’ completion of the survey.
Results
We sent email invitations to 478 providers, among whom 207 responded (total response
rate: 43.3%; 55.6% of OBCPs and 37.6% of PCPs). The median age of respondents was 41
[Interquartile range 35–50] and the median year they completed medical or nursing school
was 1994 [IQR range 1985–2000]. Among participants, 103 were internists, 77 were
obstetrician-gynecologists, 3 were midwives, 2 were family practice physicians, 12 were
pediatric or adolescent medicine specialists, and 10 did not specify a specialty. PCPs were
older, completed medical or nursing school earlier, and were almost entirely attending
physicians, whereas a third of OBCPs were residents, and 16.2% of OBCPs were nurses or
midwives (Table 1).
Most participants (81.1%) gave an estimate of risk of progression from GDM to type 2
diabetes within the range of 17–63%, which was reported in a recent meta-analysis of the
literature14. OBCPs were more likely than PCPs to correctly state ADA guidelines for the
recommended type of postpartum screening (91.3% vs. 72.4%, p = 0.001) and were less
likely to report that they were not sure what screening to order (6.3% vs. 31.5%, p <
0.0001). Few providers (12.8%) knew the ADA recommends routine screening beginning at
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age 45, and few (18.9%) knew the recommended interval for follow-up glucose testing
among women with a normal screen at the six week post-partum visit. PCPs were 4 times as
likely as OBCPs to indicate they would order glucose screening for women with a known
history of GDM (OR 3.86, 95% CI 2.11–7.09). Adjustment for provider characteristics
strengthened this association (OR 4.31, 95% CI 2.01–9.26).
Similar percentages of PCPs and OBCPs reported having both diabetes educators (81.0 vs.
81.3%, p>0.05) and nutrition materials (80.8 vs. 87.2%, p>0.05) available in their office
practice. Primary care providers were more likely to report having handouts on weight loss
(84.6 vs. 53.2%, p < 0.0001), exercise (80.7 vs. 61.5%, p=0.002) and diabetes risk factors
(65.3 vs. 39.7%, p < 0.001) available for patients. OBCPs were more likely to report not
knowing about the availability of educational materials than PCPs (40.5 vs. 10.4%, p<
0.001).
We also found differences in OB and primary care provider routines for assessing obstetric
and GDM history (Table 2). OBCPs were much more likely to use a standard intake form
for new patients than PCPs (95.0 vs. 54.0%, p < 0.0001). Among those using an intake form,
OBCPs were more likely than PCPs to include questions about both obstetrical history (96.1
vs. 72.7%, p < 0.001) and GDM history (74.3 vs. 21.5%, p < 0.001). Overall 11.4% of PCPs
(N=14) and 70.5% of OBCPs (N=55) used an intake form that assessed for history of
gestational diabetes. PCPs and OBCPs also differed with respect to whether they routinely
asked patients of reproductive age about pregnancy history and complications. OBCPs were
more likely to ask about interval pregnancies (94.9 vs. 72.3%, p < 0.0001) or gestational
diabetes history (60.3 vs. 43.7%, p =0.02), but PCPs were more likely to order glucose
screening for women with a GDM history (72.9 vs. 41.0%, p < 0.0001).
PCPs in our population were older and more likely to have completed residency and
fellowship than OBCPs. We therefore modeled the association between provider type and
screening practices, using logistic regression to adjust for age and year of completing
medical or nursing school (quartiles), level of training (attending vs. resident or fellow),
professional training (nurse or physician) and having a Master’s in Public Health (yes or no).
In the unadjusted models, PCPs were half as likely as OBCPs to ask a woman of
reproductive age about gestational diabetes history (OR 0.51, 95% CI 0.29–0.92), and
adjustment for provider characteristics modestly strengthened this association (OR 0.43,
95% CI 0.20–0.90). We asked prenatal care providers to report how often they entered a
diagnosis of gestational diabetes in to the health system’s electronic medical record; 40.4%
of providers reported updating the EMR problem list to include GDM less than half of the
time. Most PCPs (61.5%) reported receiving information about a patient’s pregnancy
outcome or complications less than 25% of the time. Consistent with these results, the
majority (54.6%) of OBCPs and PCPs identified lack of communication between providers
as a major barrier to follow-up of women with GDM. Other major barriers included lack of
familiarity with guidelines (50.0%), lack of screening for a GDM history (43.0%), and lack
of patient understanding about the long-term risks associated with GDM (41.5%). OBCPs
and PCPs opinions were similar regarding barriers (p>0.2 for all comparisons) with the
exception of follow-up for abnormal glucose screening results:13.9% percent of OBCPs
identified difficulty of follow-up as a major barrier compared with 3.4% of PCPs (p=0.01).
Documentation of GDM in the Electronic Medical Record problem list
In the survey, 93.3% of PCPs and 81.8% of OBCPs reported using the EMR problem list to
manage patient care. To explore whether existing problem list data about gestational
diabetes history could be used to improve clinical care, we queried the electronic medical
record and laboratory databases for the Partners Healthcare System. We identified 772
women with documentation of a birth at Brigham and Women’s Hospital and a GTT result
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diagnostic for gestational diabetes by Carpenter-Coustan criteria13. Among these women,
450 had at least one entry on their electronic problem list, and of these, only 141 (31.3%)
had a concept code for “Diabetes of Pregnancy.” An additional 65 women had a free text
entry on their problem list that appeared to indicate a history of gestational diabetes, for a
total of 206 women (45.8%) with some indication of a GDM history in the electronic
medical record problem list. Documentation rates were unchanged when we limited our
analysis to women with a non-emergency room outpatient visit > 60 days after their last
delivery (N=373, 31.4% with concept code for GDM, 45.8% with any documentation of
GDM), We did not find an association between documentation rates and year of last birth
(Mantel-Haenszel trend test p > 0.05).
Comment
In a survey of providers in a northeastern academic health care system, we found that most
clinicians knew that women with GDM were at high risk of developing type 2 diabetes, but
knowledge of follow-up guidelines was poor. Survey participants identified limited
communication between OB and primary care providers, and to a lesser extent lack of
provider awareness of guidelines, as major barriers to screening. Although this healthcare
system uses an advanced electronic medical record, documentation of GDM history in the
electronic problem list was poor.
Our findings must be interpreted within the context of the study design. Overall, 43% of
providers completed the survey, and individuals who completed the survey may differ from
those who did not; however, our response rate is similar to the 37 to 50% response rate for
other surveys in the literature15–18. Our survey was administered to providers within a single
academic health care system in Massachusetts, and therefore may not be generalizable to
other regions or practice models. Moreover, Partners Health Care uses a fully functional
EMR, and such electronic records are available in a minority of practice settings in the
US19, although their use appears to be rapidly increasing20. However, this setting allowed us
to compare survey responses with documentation in the electronic medical record.
Moreover, we found poor documentation of GDM history in the Partners System EMR. This
result suggests that even a fully-functional EMR is not sufficient to ensure continuity from
pregnancy to primary health care if prenatal documentation is not integrated into the primary
care record. Results in settings that do not use fully-functional EMRs might be even less
satisfactory.
Our survey assessed screening practices based on provider self-report, and we found that
both primary care providers and OB care providers were familiar with data regarding the
risks of progression to type 2 diabetes and were aware of recommendations for screening at
the postpartum visit. Consistent with our results, Gabbe et al18 reported that 74% of
respondents in a survey of ACOG members report routinely order postpartum glucose
screening. However, when authors have used medical records to determine whether patients
complete screening, they have found low utilization rates. Smirnakis et al10, in a study that
included one of the sites we studied, reported that only 37% of women with GDM received
appropriate glucose screening following pregnancy, with a median time to follow-up of 428
days, while 94% received a pap smear a median of 49 days after childbirth. Other authors
have similarly documented poor follow-up screening in the first postpartum year.9,21–23
These findings suggest that physicians may overestimate the rate of screening in clinical
practice.
In our survey, PCPs reported that they were unlikely to assess a woman’s GDM history, and
OBCPs reported that they were unlikely to order screening for women with a known history
of GDM, suggesting that few women receive recommended screening. Kauffman reported
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low rates of follow-up screening in a longitudinal study of 66 women with a history of
GDM24. All women in the Kauffman study had normal results on a postpartum 2-hour oral
glucose tolerance test, and each participant and her primary care physician received a letter
recommending annual screening for diabetes. Five years later, authors contacted participants
and found that only 30% had received the recommended annual screening. Of those who had
been screened, the physician initiated testing in 62%, whereas the patient requested
screening in 38%. Rates of screening were similarly low among obstetrician-gynecologists,
family practice physicians, and internists.
These low rates of screening are an important quality problem. Interventions for women
with GDM could substantially delay progression to type 2 diabetes25. In a functional
healthcare system, what matters most is not how individuals perform with regard to
identification of GDM in the record but rather how well the system performs at identifying
women with this issue and ensuring that women with a GDM history get the subsequent care
they need. OBCPs are focused for good reasons on issues related to pregnancy, so it is
perhaps not surprising that OBCPs performed better in this area, yet many women receive
their ongoing care with PCPs, who were unlikely to assess a woman’s pregnancy history.
The post-pregnancy transition between providers represents yet another example of
“dropping the ball” as patients make transitions within the healthcare system26. In particular,
our results suggest that communication between obstetric and primary care providers is a
major barrier to follow-up of women with GDM. In addition, we found that existing
structures and processes, such as patient intake forms, do not adequately capture a woman’s
history of gestational diabetes. OBCPs also identified follow-up for abnormal glucose
results as a major barrier to screening.
Finally, we found that most women who gave birth at BWH and had a laboratory result
diagnostic of gestational diabetes did not have this history documented in their electronic
problem list. Of note, during the study period, BWH used an electronic prenatal record that
operated independently of the primary care EMR. Both BWH and MGH have recently taken
steps to improve integration of prenatal and primary care records. In future studies, we plan
to test whether integration of obstetrical problems with the primary care record will
influence screening for and prevention of health conditions after pregnancy. Such
documentation may, in turn, increase the probability of appropriate follow-up testing. For
example, EMR-based decision support tools could alert providers to a woman’s GDM
history and include recommendations for screening. Further studies should address the
effectiveness of such interventions.
In conclusion, we found that clinicians were generally aware that women with GDM had a
high risk of developing type 2 diabetes, but they did not routinely assess and screen patients.
Key opportunities for improvement include facilitating communication between OBCPs and
PCPs and integrating obstetrical and primary care problem lists, as well supplying decision
support around testing. Further studies are needed to measure the effectiveness of such
interventions to improve follow-up of women with a history of GDM.
Acknowledgments
This study was supported by the Partners IS Research Council.
References
1. Cheung NW, Byth K. Population Health Significance of Gestational Diabetes. Diabetes Care. 2003;
26(7):2005–2009. [PubMed: 12832303]
2. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care. 2004; 27(90001):
88S–90S.
Stuebe et al. Page 6













3. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 435:
Postpartum Screening for Abnormal Glucose Tolerance in Women Who Had Gestational Diabetes
Mellitus. Obstet Gynecol. 2009; 113(6):1419–1421. [PubMed: 19461459]
4. O'Sullivan JB. Gestational diabetes. Unsuspected, asymptomatic diabetes in pregnancy. N Engl J
Med. 1961; 264:1082–1085. [PubMed: 13730123]
5. Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with
Lifestyle Intervention or Metformin. N Engl J Med. 2002; 346(6):393–403. [PubMed: 11832527]
6. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of Type 2 Diabetes Mellitus by Changes
in Lifestyle among Subjects with Impaired Glucose Tolerance. N Engl J Med. 2001; 344(18):1343–
1350. [PubMed: 11333990]
7. Pan X, Li G, Hu Y, et al. Effects of diet and exercise in preventing NIDDM in people with impaired
glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997; 20(4):537–544.
[PubMed: 9096977]
8. Chiasson J-L, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the
STOP-NIDDM randomised trial. The Lancet. 2002; 359(9323):2072–2077.
9. Kim C, Tabaei BP, Burke R, et al. Missed Opportunities for Type 2 Diabetes Mellitus Screening
Among Women With a History of Gestational Diabetes Mellitus. Am J Public Health. 2006 AJPH.
2005.065722.
10. Smirnakis KV, Chasan-Taber L, Wolf M, et al. Postpartum Diabetes Screening in Women With a
History of Gestational Diabetes. Obstet Gynecol. 2005; 106(6):1297–1303. [PubMed: 16319255]
11. Sequist TD, Gandhi TK, Karson AS, et al. A Randomized Trial of Electronic Clinical Reminders
to Improve Quality of Care for Diabetes and Coronary Artery Disease. J Am Med Inform Assoc.
2005; 12(4):431–437. [PubMed: 15802479]
12. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines?
A framework for improvement. JAMA. 1999; 282(15):1458–1465. [PubMed: 10535437]
13. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet
Gynecol. 1982; 144(7):768–773. [PubMed: 7148898]
14. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a
systematic review. Diabetes Care. 2002; 25(10):1862–1868. [PubMed: 12351492]
15. Gabbe S, Hill L, Schmidt L, Schulkin J. Management of diabetes by obstetrician-gynecologists.
Obstet Gynecol. 1998; 91(5 Pt 1):643–647. [PubMed: 9572204]
16. Power ML, Cogswell ME, Schulkin J. Obesity prevention and treatment practices of U.S.
obstetrician-gynecologists. Obstet Gynecol. 2006; 108(4):961–968. [PubMed: 17012460]
17. Ramsey PS, Nuthalapaty FS, Lu G, et al. Contemporary management of preterm premature rupture
of membranes (PPROM): a survey of maternal-fetal medicine providers. Am J Obstet Gynecol.
2004; 191(4):1497–1502. [PubMed: 15507990]
18. Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J. Management of diabetes mellitus by
obstetrician-gynecologists. Obstet Gynecol. 2004; 103(6):1229–1234. [PubMed: 15172857]
19. DesRoches CM, Campbell EG, Rao SR, et al. Electronic Health Records in Ambulatory Care -- A
National Survey of Physicians. N Engl J Med. 2008; 359(1):50–60. [PubMed: 18565855]
20. Simon SR, Soran CS, Kaushal R, et al. Physicians' use of key functions in electronic health records
from 2005 to 2007: a statewide survey. J Am Med Inform Assoc. 2009; 16(4):465–470. [PubMed:
19390104]
21. Almario CV, Ecker T, Moroz LA, et al. Obstetricians seldom provide postpartum diabetes
screening for women with gestational diabetes. Am J Obstet Gynecol. 2008; 198(5):528 e521–528
e525. [PubMed: 18191799]
22. Dietz PM, Vesco KK, Callaghan WM, et al. Postpartum screening for diabetes after a gestational
diabetes mellitus-affected pregnancy. Obstet Gynecol. 2008; 112(4):868–874. [PubMed:
18827130]
23. Hunt KJ, Conway DL. Who returns for postpartum glucose screening following gestational
diabetes mellitus? Am J Obstet Gynecol. 2008; 198(4):404 e401–404 e406. [PubMed: 18241820]
24. Kaufmann RC, Smith T, Bochantin T, et al. Failure to obtain follow-up testing for gestational
diabetic patients in a rural population. Obstet Gynecol. 1999; 93(5 Pt 1):734–737. [PubMed:
10912976]
Stuebe et al. Page 7













25. Bentley-Lewis R, Levkoff S, Stuebe A, Seely EW. Gestational diabetes mellitus: postpartum
opportunities for the diagnosis and prevention of type 2 diabetes mellitus. Nat Clin Pract
Endocrinol Metab. 2008; 4(10):552–558. [PubMed: 18779843]
26. Gandhi TK, Kachalia A, Thomas EJ, et al. Missed and delayed diagnoses in the ambulatory
setting: a study of closed malpractice claims. Ann Intern Med. 2006; 145(7):488–496. [PubMed:
17015866]
Stuebe et al. Page 8

























Stuebe et al. Page 9
Table 1
Characteristics of survey respondents (N=207)
All providers OB providers
Primary care
providers P*



















% (n) % (n) % (n)
Professional training
Nurse or midwife 7.3 (15) 16.2 (13) 1.6 (2) <0.001
Physician 92.7 (192) 83.8 (67) 98.4 (125)
Level of training among MDs <0.001
Resident/fellow 13.6 (25) 34.9 (23) 1.7 (2)
Attending 84.8 (156) 65.1 (43) 95.8 (113)
Missing 1.6 (3) 0 (0) 2.5 (3)
Master's in public health 0.96
Yes 11.1 (23) 11.3 (9) 11.0 (14)
*
Wilcoxon rank sum test p value for continuous variables and chi-square p value for categorical variable, OB vs. primary care providers.
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Table 2









% (N) % (N) % (N) P*
N 207 80 127
Does your practice use a standard intake form for new patients?
Yes 69.9 (144) 95.0 (76) 54.0 (68) <0.001
If yes, does this form include questions about:
  Risk factors for Diabetes 78.6 (110) 81.3 (61) 75.4 (49) 0.39
  OB history 85.2 (121) 96.1 (73) 72.7 (48) <0.001
  GDM history 49.6 (69) 74.3 (55) 21.5 (14) <0.001
Consider women of reproductive age that you have seen for office visits in the past
month. At least 50% of the time, did you:
Ask about interval pregnancies 81.2 (160) 94.9 (74) 72.3 (86) <0.0001
Ask about gestational diabetes history 50.3 (99) 60.3 (47) 43.7 (52) 0.02
Order glucose screening for patients with a GDM history 60.2 (118) 41.0 (32) 72.9 (86) <0.0001
*
Chi-square test, OB providers vs. primary care providers.
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